Source comparison
GHRP-2 vs GHRP-6: Historical and Modern Research Context
The GHRP-2 vs GHRP-6 comparison spans over 30 years of GH secretagogue research. GHRP-6 was the pioneer — the compound that proved synthetic ghrelin mimetics could drive pulsatile GH release and led to the discovery of the GHS-R1a receptor (Smith et al., 1996,
This comparison does not assign a generated winner or score.
- The GHRP-2 vs GHRP-6 comparison spans over 30 years of GH secretagogue research. GHRP-6 was the pioneer — the compound that proved synthetic ghrelin mimetics could drive pulsatile GH release and led to the discovery of the GHS-R1a receptor (Smith et al., 1996, Science) and ghrelin itself (Kojima et al., 1999, Nature). GHRP-2 was developed as a second-generation improvement — retaining GHRP-6’s GH potency while reducing appetite and off-target effects.
- In 2026, both compounds remain actively used because the GHRP-2 vs GHRP-6 tradeoff has not been “solved” by either compound. When researchers need maximum GH with manageable sides: GHRP-2. When researchers need GH with appetite boost and cardioprotection: GHRP-6. When researchers need clean GH with zero sides: Ipamorelin. Each compound in the GH secretagogue family serves a distinct research niche that the others cannot fill. PSPeptides carries all three.